• StemVax relies on cutting-edge research and
    creativity to face the unknown

  • Keeping dreams alive through immunotherapy

  • A new way of treating disease,
    stem cell immunology

Cutting-edge research & creativity to face the unknown
Keeping dreams alive
through immunotherapy
A new way of treating disease, stem cell immunology

Welcome

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells.

We seek to make a difference in patient’s lives. Bringing new beginnings to the market by developing novel therapeutics.

Events

BIO Investor Conference, San Francisco, Oct. 17-18, 2018.

SFN Conference, Convention Center, San Diego, CA.